The prefilled syringe fill / finish services market is estimated to is estimated to reach close to USD 3 Billion by 2030
The numerous benefitsoffered by prefilled syringes, coupled to the growing self-medication trend,have led to the approval of a number of drugs in combination with such devices,resulting in an increase in need to outsource fill / finish operations
Roots Analysis is pleased toannounce the publication of its recent study, titled, “PrefilledSyringe Fill / Finish ServicesMarket, 2020-2030.”
The report features an extensive study of thecurrent market landscape and future opportunities for contract serviceproviders offering fill finish services for prefilled syringes. The studyfeatures an in-depth analysis of the key drivers and trends related to thisevolving domain. Amongst other elements, the report includes:
§ A detailed review ofthe overall landscape of companies offering contract fill / finish services forprefilled syringes
§ Tabulated profiles ofkey players (shortlisted based on a proprietary criterion) across keygeographies, such as North America, Europe and Asia-Pacific.
§ An analysis of therecent developments (since 2015) pertaining to contract fill / finish services,based on various parameters
§ An estimate of theglobal, contract fill / finish capacity of prefilled syringes, by taking intoconsideration the capacities of various fill / finish service providers (asavailable on respective company websites), collected via secondary and primaryresearch.
§ An informed estimateof the annual demand for fill / finish of prefilled syringes (in number ofunits), taking into account the marketed drugs available in prefilled syringesand other relevant parameters, such as target patient population, dosingfrequency and dose strength.
§ A detailed demand andsupply assessment of geographies in this domain.
§ An analysispresenting potential strategic partners (primarily drug developers) forprefilled syringe fill / finish service providers.
§ A discussion on thepotential growth areas in this domain.
§ A review of thelandscape of prefilled syringe manufacturers.
§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)
- Scale of Operation
§ Preclinical /Clinical
§ Commercial
- Type of Drug Molecule
§ Biologic
§ Small Molecule
- Target Therapeutic Area
§ Blood Disorders
§ Infectious Diseases
§ Metabolic Disorders
§ Oncological Disorders
§ Neurological Disorders
§ Autoimmune Disorders
§ Others
- Syringe Barrel Material
§ Glass
§ Plastic
- Number of Barrel Chambers
§ Single Chamber
§ Dual Chamber
- Key Geographical Region
§ North America
§ Europe
§ Latin America
§ Asia-Pacific
§ Middle East andAfrica
Keycompanies covered in the report
§ Ajinomoto Bio-Pharma Services
§ AMRI
§ BioPharma Solutions
§ Emergent BioSolutions
§ Patheon
§ Consort Medical
§ EVER Pharma
§ GlaxoSmithKline
§ IDT Biologika
§ Rentschler Biopharma
§ Siegfried
§ Vetter Pharma
§ Biocon
§ Intas Pharmaceuticals
§ Kemwell Biopharma
§ Square Pharmaceuticals
Formore information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html
Other RecentOfferings
1. PrefilledSyringes Market (5th Edition), 2020-2030
2. BiologicsFill / Finish Services Market, 2019-2030
About Roots Analysis
Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
